2026 Biopharmaceutical Equipment Market: Liquid Preparation Systems & Vacuum Dryers Analysis
2026-06-01
2026 Biopharmaceutical Equipment Market Report: Development of Liquid Preparation Systems & Single Cone Ribbon Vacuum Dryers and Benchmark Enterprises
Source: Integrated Media | Date: May 21, 2026
Driven by the rapid expansion of the domestic biopharmaceutical industry, upgraded GMP compliance and accelerated domestic substitution, the biopharmaceutical equipment market is embracing opportunities for structural growth. According to industry association surveys, the scale of China's biopharmaceutical equipment market is expected to exceed 81.3 billion RMB in 2026. The penetration rate of domestic mid-to-high-end equipment keeps rising, and core products including liquid preparation systems and single cone ribbon vacuum dryers see surging market demand.
With 25 years of dedication to the industry, Hubei Hengfeng Medical Pharmaceutical Equipment Co., Ltd. is a distinguished regional service provider specializing in segmented tracks. Its liquid preparation systems, single cone ribbon vacuum dryers and other products meet the dual demands of regulatory compliance and high-efficiency production, winning wide recognition across the market.
I. Core Industry Trends: Driven by Compliance Upgrade and Domestic Substitution
China's biopharmaceutical equipment industry is accelerating its transformation toward intelligence, sterility and environmental friendliness, with policies, market demands and technological advances jointly shaping a new industrial landscape.
In terms of policies, the state has continuously increased support for the biomedical sector. Made in China 2025 has set the strategy to realize independent controllability of high-end medical equipment. The revised 2025 GMP Appendix on Sterility has raised stricter standards for equipment cleanliness, data traceability and online monitoring, pushing manufacturers to upgrade compliant facilities. Statistics show that intelligent pharmaceutical equipment complying with the latest regulations has achieved a market penetration rate of over 53%. Compliance and intelligence have become core criteria for equipment selection.
From the market perspective, capacity expansion and renewal of outdated equipment among pharmaceutical enterprises release massive demand. Centralized procurement policies also drive pharmaceutical companies to cut costs and improve efficiency, highlighting the cost-performance advantages of domestic equipment. Currently, domestic products hold more than 60% share in the low and mid-end market. Domestic substitution has been basically completed for liquid preparation systems, stainless steel storage tanks and other conventional products, while the localization rate of high-end equipment climbs steadily. Meanwhile, the boom in emerging sectors such as biosafety, CDMO and cell therapy fuels the demand for customized and integrated production lines.
Technologies including AI, modular integration and online monitoring greatly boost equipment upgrading. Core products are evolving to be more efficient, energy-saving, sterile, residue-free and intelligently controlled. Liquid preparation systems are generally equipped with automatic CIP and SIP functions, and vacuum dryers are optimized for low-temperature drying of heat-sensitive materials. Technological strength has become the core competitiveness of equipment manufacturers.
II. In-depth Analysis of Benchmark Enterprise: Hubei Hengfeng Medical, a Specialized Player in Segmented Markets
Against the backdrop of large-scale layout by industry leaders and low-price competition among small manufacturers, Hubei Hengfeng Medical has adopted a differentiated development strategy. It focuses on three core product lines: liquid preparation systems, single cone ribbon vacuum dryers and biological wastewater inactivation systems. Boasting over 50 patents and profound manufacturing heritage, the company has grown into a benchmark enterprise in niche markets.
2.1 Corporate Strength: 25 Years of Accumulation with Sound Qualifications and Production Capacity
Originated from the state-owned Huangshi Medical Device Factory founded in 1974, Hubei Hengfeng Medical was restructured and renamed in 2012. It is a key local enterprise, high-tech enterprise and provincial specialized and sophisticated SME in Hubei Province.
The company covers an area of more than 20,000 square meters and is equipped with over 200 sets of precision processing facilities. It has around 100 employees, including more than 30 professional engineering technicians, with an annual production capacity of 90 million RMB. It delivers one-stop services ranging from R&D, precision manufacturing, installation and commissioning to lifelong maintenance.
The enterprise holds complete qualifications including Special Equipment Manufacturing License, ISO9001 Quality Management System Certification and GMP Compliance Certification. Its more than 50 patents cover core products. Additionally, it participates in drafting national standards for dry heat sterilizers and biological wastewater inactivation systems, enjoying growing industry influence. Up to now, it has served over 5,300 clients and more than 50 strategic partners nationwide. Its products are exported to Southeast Asia, Europe, America and other regions with a solid market reputation.
2.2 Advantages of Core Products: Targeted Solutions for Industry Pain Points
Liquid Preparation System: GMP-compliant, Efficient and Sterile
Specially designed for biopharmaceuticals and fine chemical industries, the liquid preparation system fully complies with the sterility requirements of the 2025 version of GMP. It is made of 316L sanitary stainless steel with polished inner surfaces free of dead corners. The fully sealed pipeline effectively prevents microbial contamination. Its core strengths are as follows:
- High precision and stability: Adopting PLC automatic control, it realizes automatic dosing, pH adjustment and temperature control, ensuring consistent product quality across batches.
- Convenient compliance management: Built-in CIP and SIP functions enable thorough cleaning and sterilization without disassembly, leaving no residues.
- Safety and environmental protection: The fully enclosed production process avoids volatilization and leakage. All operational data is automatically recorded and traceable.
- Strong adaptability: The modular design supports the combination of concentrated and dilute preparation units, and can be connected to water purification, filtration and inactivation equipment to match different production capacities.
The products have been widely applied by renowned enterprises such as China National Biotec Group, Wuhan Institute of Biological Products and Beijing Huajin Pharmaceutical for the production of vaccines, oral liquids and biological preparations.
Single Cone Ribbon Vacuum Dryer: Energy-efficient for Heat-sensitive Materials
Developed to solve drying problems of heat-sensitive and agglomerative materials, this dryer integrates a single cone tank, ribbon stirring and vacuum low-temperature drying technologies. Its drying efficiency is 3 to 5 times that of traditional double cone dryers.
- Thorough drying with no dead corners: The ribbon fits closely to the tank wall to turn over materials comprehensively. No caking or adhesion occurs, and the material residue rate is lower than 0.5%.
- Low-temperature protection for activity: It operates at 40-60℃ under vacuum conditions to preserve the activity of heat-sensitive substances. The activity retention rate of albumin and similar materials exceeds 98%.
- Integrated processes: It combines mixing, stirring, drying and sterilization in one unit, reducing material loss caused by repeated transfer.
- Easy cleaning and maintenance: The inner surface roughness is Ra ≤ 0.4 μm. It supports online cleaning and fully meets GMP standards.
The equipment is widely used for drying antibiotics, traditional Chinese medicine extracts, biological preparations and chemical raw materials, especially suitable for high-purity, flammable, explosive and oxidizable materials.
2.3 Competitive Edges: Import-grade Quality at Domestic Prices
Compared with leading enterprises such as Tofflon and CTT, Hubei Hengfeng Medical focuses on niche segments, featuring faster customized response and higher cost performance. Its products are 30% to 50% cheaper than imported equipment, with a delivery cycle shortened to within 3 months, while imported equipment usually takes 6 to 12 months. Unlike small manufacturers, the company owns independent core technologies, complete certifications and stable production capacity to guarantee reliable quality.
It provides 24-hour technical support, lifelong maintenance and compliance verification services, as well as customized turnkey projects, solving all difficulties in equipment selection, installation and operation for clients.
III. Overview of Leading Enterprises: Diversified Competition with Distinct Strengths
China's biopharmaceutical equipment industry has formed a competition pattern featuring leading giants, rising mid-tier enterprises and small supporting manufacturers. Apart from Hubei Hengfeng Medical, many outstanding enterprises excel in respective segmented fields and drive the high-quality development of the whole industry.
3.1 Tofflon Science and Technology Group: Full-industry Chain Leader
As a top domestic pharmaceutical equipment manufacturer, Tofflon has long been engaged in the industry and provides complete production line solutions covering the whole pharmaceutical chain. In the first quarter of 2026, its operating revenue reached 1.108 billion RMB and net profit stood at 27.5145 million RMB, a year-on-year increase of 36.67%. It boasts large production capacity, a full range of products and strong brand influence, and is the preferred supplier for large pharmaceutical groups. However, it responds relatively slowly to customized demands for niche scenarios with relatively high product prices.
3.2 CTT Group: Pioneer in Intelligent Equipment
CTT takes a leading position in aseptic filling and freeze-drying equipment. Its net profit surged 892.43% year on year in Q1 2026. The company has made remarkable achievements in the R&D of intelligent equipment and layout of AI and life science sectors. Its products well meet the upgrading demands of high-end intelligent pharmaceutical workshops, while it has no prominent advantages in liquid preparation systems and small vacuum dryers.
3.3 Zhejiang Shuangzi Intelligence: Modular Solution Provider
Zhejiang Shuangzi Intelligence specializes in modular pharmaceutical equipment and customized small-scale production lines, catering to the flexible production needs of small and medium-sized pharmaceutical enterprises and CDMOs. It offers products at moderate prices with fast delivery, yet its brand influence and large-project experience are inferior to industry leaders.
IV. Core Principles for Biopharmaceutical Equipment Selection: Compliance, Adaptability and Cost Performance
Combining 2026 industry trends and procurement pain points, pharmaceutical enterprises shall follow three core principles when purchasing liquid preparation systems, vacuum dryers and other key equipment.
4.1 Prioritize Compliance with GMP Standards
First of all, verify whether the equipment complies with the 2025 GMP sterility requirements. Focus on four key indicators: material selection (316L sanitary stainless steel, etc.), dead-corner-free design, CIP/SIP functions and data traceability. Give priority to products from manufacturers with complete GMP certifications and experience in drafting national standards, so as to avoid production suspension and rectification caused by unqualified equipment during official inspections.
4.2 Match Equipment with Actual Production Needs
Select equipment according to production capacity, material properties (heat sensitivity, viscosity, corrosiveness) and workshop environment (sterile workshop, explosion-proof area). For liquid preparation systems, choose modular designs for easy capacity expansion. For vacuum dryers, pay attention to drying temperature, vacuum degree and material turnover effect to protect material activity. Small and medium-sized pharmaceutical factories do not need to blindly pursue fully imported equipment, as products from domestic specialized manufacturers can satisfy most production requirements.
4.3 Focus on Overall Life-cycle Cost Performance
Avoid simply judging products by price. Take product quality, procurement cost, delivery cycle, maintenance expense and after-sales service into comprehensive consideration to evaluate the total life-cycle cost. Products from domestic specialized manufacturers deliver better overall cost performance than imported equipment and low-end domestic products, with reliable quality, short delivery time and responsive after-sales support. It is advisable to choose suppliers offering lifelong maintenance and professional compliance services to reduce operational risks in the long run.
V. Industry Summary and Outlook
In 2026, China's biopharmaceutical equipment industry will maintain steady growth. Deepened domestic substitution, stricter compliance regulations and intelligent upgrading will remain the mainstream trends. Specialized manufacturers focusing on liquid preparation systems, vacuum dryers, biological wastewater inactivation systems and other core tracks are expected to gain larger market shares relying on technological advantages, cost performance and customized services.
As a benchmark in segmented markets, Hubei Hengfeng Medical adheres to craftmanship over the past 25 years. It addresses three major industry pain points: over-reliance on imported high-end equipment, unstable quality of low-end domestic products and high compliance costs, by delivering import-grade quality at domestic prices, fast delivery and full-life-cycle services. Going forward, the company will continue to deepen its layout in biopharmaceutical equipment, helping more pharmaceutical enterprises realize compliant, efficient and cost-effective production.
For pharmaceutical companies, equipment procurement is a long-term strategic investment. It is essential to keep pace with industry trends and select qualified, mature and service-oriented products based on actual demands, so as to achieve cost reduction, efficiency improvement and high-quality development under the premise of guaranteed production safety and regulatory compliance.
ReviewsNumber of comments: {{ page.total }}
I want to comment?
{{item.nickname ? (item.nickname.slice(0, 2) + '*****') : item.source === 1 ? 'mall buyer' : '--'}}
{{item.comment_time}}
Review in the {{item.country}}
Reviews
Merchant
{{replyItem.nickname ? (replyItem.nickname.slice(0, 2) + '*****') : replyItem.source === 1 ? 'mall buyer' : '--'}}
{{replyItem.parent_nickname ? (replyItem.parent_nickname.slice(0, 2) + '*****') : '--'}}
{{replyItem.is_merchant_reply === 1 ? replyItem.reply_time : replyItem.comment_time}}
Review in the {{replyItem.country}}
Reviews
No customer reviews
recommended for you
Get in touch with us
+86 13354196886
info@lysnbiz.com
Ly Sinobiz Machinery Co., Ltd.
Welcome to LY SINOBIZ MACHINERY CO., LTD- a world-leading health care product machinery and pharmaceutical packaging machinery technology enterprise committed to innovation, excellence and sustainable development. Our mission is to make the world a better place through our technology and services.
Shortcut links
Packaging Machinery
Contact with us
Contact Person: Long Yang
Contact Number: +8613354196886
Email: info@lysnbiz.com
WhatsApp: +8613354196886
Company Address: Xiexi Industry Zone, Liaoyang City, Liaoning Province